IP Library › Assignment 066864/0457
Patent Assignment
Reel/Frame 066864/0457

Assignment of Assignor's Interest

Recorded: 2024-03-22 Pages: 5
Assignors
YANG, FANGLONG
Executed: 2023-02-10
ZHANG, LING
Executed: 2023-02-10
ZHENG, LIANGLIANG
Executed: 2023-02-10
HE, FENG
Executed: 2023-02-10
TAO, WEIKANG
Executed: 2023-02-10
Assignees
JIANGSU HENGRUI PHARMACEUTICALS CO., LTD.
NO. 7 KUNLUNSHAN ROAD, ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE, LIANYUNGANG, JIANGSU, 222047, CHINA
SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD.
NO. 279 WENJING ROAD, MINHANG DISTRICT, SHANGHAI, 200245, CHINA
Covered Property (1)
Fused Imidazole Derivative, Preparation Method Therefor, and Medical Use Thereof
Application: 18/612,631 →
Publication: US 2024/0246958
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 20, 2024
From: YANG, FANGLONG; CHANG, LING; ZHENG, LIANGLIANG; HE, FENG
To: SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD.
Reel/Frame 069335/0114 →
Assignment of Assignor's Interest Nov 20, 2024
From: SHANGHAI HENGRUI PHARMACEUTICAL CO., INC.
To: JIANGSU HENGRUI PHARMACEUTICALS CO., LTD.
Reel/Frame 069335/0180 →
Corrective Assignment to Correct the the Name of the Second Inventor Previously Recorded at Reel: 69335 Frame: 114. Assignor(S) Hereby Confirms the Assignment. Dec 16, 2024
From: YANG, FANGLONG; ZHANG, LING; ZHENG, LIANGLIANG; HE, FENG
To: SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD.
Reel/Frame 070746/0422 →